Switch to:
More From Other Websites
Novogen And CanTx Appoint Contract Manufacturers To Produce Clinical Batches Of Cantrixil™ Jul 25 2014
Novogen and CanTx Announce Potency of Intra-Peritoneal Trx-1 Confirmed Against Chemo-Resistant... Jun 17 2014
5 Reasons Why We Believe Novogen Is Poised For Success Jun 05 2014
Novogen rises 14.7% May 27 2014
Novogen Identifies Highly Active Drug Candidates Against Prostate Cancer May 27 2014
Children's Oncology Drug Alliance (CODA) Formed to Facilitate Development of Treatments for... May 04 2014
Novogen and Genea Announce Partnership to Investigate Promising New Approach to Neurodegenerative... May 02 2014
Novogen and CanTx Experimental Drug, Trx-1, Proves Effective in Vivo Mar 18 2014
Novogen to Present at 2nd Annual Sachs Cancer Bio Partnering & Investment Forum in New York Mar 12 2014
Novogen Selected to Present at Cavendish Global Health Impact Forum Mar 10 2014
Novogen appoints David Gryska as strategic advisor Mar 04 2014
Novogen Appoints New Board Members and Strategic Advisor to Support Transition to Clinical... Mar 04 2014
Novogen Announces Key Appointments to Drive Development of Anti-Tropomyosin Drug Platform Feb 03 2014
Novogen to Host Corporate Update and Webcast Jan 30 2014
Novogen to Present at Biotech Showcase™ 2014 Jan 08 2014
Novogen Announces Establishment of Global Collaboration to Drive The Development of Drugs to Treat... Dec 20 2013
Novogen Files Suite of Patents for Anti-Tropomyosin Drug Technology Nov 26 2013
Wal-Mart’s Soft Quarter, Rio Tinto’s Arizona Mine Project, and 3 More Hot Stocks Nov 14 2013
NOVOGEN LTD Financials Nov 07 2013
Novogen Launches Joint Venture Aimed At Developing Drugs to Fight Ovarian Cancer Nov 06 2013


Add Notes, Comments or Ask Questions

User Comments

No comment yet


Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK
Email Hide